Abatacept in ANCA Associated Vasculitis
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Abatacept in ANCA Associated Vasculitis is a clinical trial[1].
Key Facts
- Abatacept in ANCA Associated Vasculitis is in the country of United Kingdom[2].
- Abatacept in ANCA Associated Vasculitis's instance of is recorded as clinical trial[3].
- Abatacept in ANCA Associated Vasculitis's start time is recorded as +2007-11-30T00:00:00Z[4].
- Abatacept in ANCA Associated Vasculitis's end time is recorded as +2008-11-30T00:00:00Z[5].
- Abatacept in ANCA Associated Vasculitis's contributor to the creative work or subject is recorded as Bristol-Myers Squibb[6].
- Abatacept in ANCA Associated Vasculitis's sponsor is recorded as Imperial College London[7].
- Abatacept in ANCA Associated Vasculitis's main subject is recorded as microscopic polyangiitis[8].
- Abatacept in ANCA Associated Vasculitis's main subject is recorded as vasculitis[9].
- Abatacept in ANCA Associated Vasculitis's number of participants is recorded as {'unit': '1', 'amount': '+7'}[10].
- Abatacept in ANCA Associated Vasculitis's title is recorded as A Pilot Study Examining the Effect of Abatacept in ANCA Associated Vasculitis[11].
- Abatacept in ANCA Associated Vasculitis's short name is recorded as ABAVAS[12].
- Abatacept in ANCA Associated Vasculitis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[13].
- Abatacept in ANCA Associated Vasculitis's ClinicalTrials.gov ID is recorded as NCT00482066[14].
- Abatacept in ANCA Associated Vasculitis's research intervention is recorded as abatacept[15].
- Abatacept in ANCA Associated Vasculitis's clinical trial phase is recorded as phase II clinical trial[16].
- Abatacept in ANCA Associated Vasculitis's study type is recorded as interventional study[17].